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Background: A revised Goldman Cardiac Risk Index has been suggested to identify patients at higher risk for cardiac
complications in patients who undergo major noncardiac surgery. The aim of this study was to test the usefulness of this
model in an independent series of patients who underwent abdominal aortic surgery and to compare the index with the
multiple gated acquisition (MUGA) scan in the prediction of cardiac complications.
Methods: We studied 77 patients who underwent MUGA scan before elective abdominal aortic reconstruction. The revised
index was calculated for each patient after recording the following five risk factors: history of ischemic heart disease,
congestive heart failure, cerebrovascular disease, insulin-dependent diabetes, and creatinine level more than 2 mg/dL.
Technetium-99m MUGA scan provided information about the resting left ventricular ejection fraction (LVEF) and the
presence of regional wall motion abnormalities.
Results: Fourteen patients (18%) had cardiac complications develop. The index proved to be a satisfactory predictor of
postoperative cardiac events (P  .008), and an abnormal LVEF failed to do so (P  .1). The presence of wall
abnormalities, with or without an abnormal LVEF, predicted cardiac complications (P  .004 and P  .006). Patients
with a higher index score showed a tendency to have a lower LVEF (Spearman rank correlation, r  0.43; P < .001).
Wall abnormalities, with or without an abnormal LVEF, were more frequent in patients with higher scores (P .03 and
P  .009). Combining the index with the LVEF or the wall abnormalities or both could further stratify the cardiac risk
(P  .004, P  .0003 and P  .0006, with 2 test for trend).
Conclusion: For those patients who undergo elective abdominal aortic surgery, the revised Goldman Cardiac Risk Index
is a simple method of evaluating cardiac risk with minimum resource implications. MUGA scan can offer additional
stratification in patients judged with the index to be at high risk. (J Vasc Surg 2002;35:943-9.)
The occurrence of life-threatening cardiac complica-
tions during and after major noncardiac procedures has
long been recognized. This is most evident in vascular
surgery in which the perioperative cardiovascular event rate
is about 8%.1 Abdominal aortic surgery, in particular, car-
ries an increased risk for cardiac complications with as much
as 40% of the perioperative deaths being cardiac in origin.2
One of the aims of cardiac assessment in candidates for
major vascular procedures is to determine the risk of a
perioperative cardiac event. This has led to an ever-expand-
ing range of costly preoperative investigations, but uniform
use of such testing has not been achieved.3-5 In the last two
decades, numerous studies have attempted to identify pa-
tients at cardiac risk with clinical markers or specialized
testing. Recently, it has been suggested that expensive
noninvasive tests for coronary artery disease are most useful
in patients whose clinical data suggest moderate risks for
cardiac complications and that they have limited impact in
high-risk or low-risk groups.6-8 Therefore, clinical data play
an important role in cardiac risk stratification, and, in this
era of cost containment, their value could not be overem-
phasized. Clinical scoring systems and cardiac indices, such
as the Goldman Cardiac Risk Index, the Detsky modifica-
tion of the original Goldman index, and the Larsen index,
are useful in the identification of high risk groups for
cardiac complications, but their use in clinical practice has
been limited by the complexity of their formats.9-14 In
1999, Lee et al14 derived and validated a simple revised
Goldman Cardiac Risk Index that included the following
six risk factors: high-risk type of surgery, known history of
ischemic heart disease, congestive heart failure, previous
stroke or transient ischemic attack, insulin-dependent dia-
betes, and creatinine level more than 2 mg/dL. Patients
with fewer than two of these risk factors were at low risk of
postoperative cardiac complications, and those with two or
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more risk factors had a 6% risk of cardiac complications.14
The authors concluded that this simple index may be useful
for identification of candidates for further risk stratification
with noninvasive testing or other management strategies.
In our institution, since 1994, cardiac risk stratification
before abdominal aortic reconstruction includes estimation
of resting radioisotope left ventricular ejection fraction
(LVEF) by means of multiple gated acquisition (MUGA)
scan. To determine whether the revised Goldman Cardiac
Risk Index could reliably stratify candidates for abdominal
aortic surgery, we retrospectively applied the revised index
in an existing database of patients who underwent cardiac
evaluation with MUGA scan at our hospital. The aim of the
study was, first, to test the usefulness of this new model in
an independent series of patients who underwent infrarenal
abdominal aortic surgery and, second, to compare this
index with radioisotope ejection fraction measurements in
the prediction of postoperative cardiac complications.
METHODS
During a 4-year period, from August 1994 to August
1998, preoperative cardiac assessment with resting MUGA
scan was undertaken in 96 patients referred to the vascular
clinic for consideration of abdominal aortic reconstruction.
Their clinical files were reviewed, and information was
stored in a computer database (Microsoft Excel 97, Mi-
crosoft Limited, Reading, United Kingdom). This existing
database was used to test the application of the revised
Goldman Cardiac Risk Index. Demographic and clinical
data were recorded, with particular emphasis on five of the
six preoperative risk factors that are included in the revised
index: 1, known history of ischemic heart disease, defined as
history of myocardial infarction, history of positive exercise
test results, current angina, use of nitrate therapy, or elec-
trocardiogram (ECG) results with pathologic Q waves; 2,
congestive heart failure (on examination, history, or chest
radiograph); 3, previous stroke or transient ischemic attack;
4, insulin-dependent diabetes; and 5, serum creatinine level
of more than 2 mg/dL. The scoring system assigned 1
point to each variable. By definition, because all patients in
this study underwent high-risk abdominal surgery, there
were no patients scoring 0 points, the minimum score for a
patient with no other risk factor being 1. The number of
risk factors for each patient was compared with outcome in
terms of postoperative cardiac events. As suggested by Lee
et al,14 patients were divided into two groups according to
the number of risk factors present: a low-risk group with
less than two risk factors and a high-risk group with two or
more risk factors.15
Resting LVEF was routinely estimated with MUGA
scan, and any evidence of disturbances in phase and wall
images were noted as evidence of myocardial wall motion
abnormality. MUGA scan was performed with a standard
ECG-gated equilibrium technique after in vivo labeling of
red blood cells with 600-MBq technetium-99m pertechne-
tate after stannous pyrophosphate priming (4 mg stannous
fluoride and 6.8 mg sodium medronate reconstituted in 6
mL to 2 mL of this are administered for priming). A
three-lead ECG was attached to the patient to give a
distinct R wave, which was used to enable the trigger to the
gated acquisition cycle. The gamma camera was an ADAC
Vertex double-headed digital system with a Pegasus pro-
cessor (ADAC Laboratories, Milpitas, Calif). Measure-
ments were taken in the left anterior oblique 45-degree
projection for 15 minutes with 16 frames per cardiac cycle
on a 64 64 computer matrix. The LVEF, calculated with
this method, was considered as healthy when it was more
than 50%. For the purpose of analysis, patients were divided
according to their LVEF into two groups, one with LVEF
of more than 50% and one with LVEF of 50% or less. They
were also divided depending on the presence or absence of
myocardial wall abnormalities. Finally, those patients with
both an abnormal LVEF and wall abnormalities were com-
pared with the rest of the patients.
Operations were performed with combined general
and epidural anesthesia. A transperitoneal approach was
used in all patients. Postoperative cardiac complications
were defined as those that occurred within 30 days of
surgery or during the hospital stay when this exceeded the
30-day period. The diagnosis of myocardial infarction re-
quired diagnostic ECG changes, a greater than 5% myocar-
dial band fraction of creatine phosphokinase, or postmor-
tem evidence. Cardiac enzymes were not measured
routinely but were requested only if there were symptoms
or ECG changes. Congestive heart failure was diagnosed in
patients with both clinical and radiologic evidence of pul-
monary congestion and a raised pulmonary capillary wedge
pressure in those patients with a pulmonary artery flotation
catheter in situ. Ventricular tachyarrhythmia was defined as
a documented ventricular tachycardia or fibrillation with
hemodynamic compromise. Unstable angina was defined as
severe precordial chest pain lasting 30 minutes or more,
unresponsive to nitroglycerine and rest, and associated with
transient ST or T wave changes without development of Q
waves or cardiac enzyme abnormalities. Other minor car-
diac complications included less severe episodes of angina
or arrhythmias not requiring treatment in an intensive
care/coronary care unit setting.
Statistical analysis was performed with the statistical
software StatsDirect (CamCode, Ashwell, Herts, UK). Sta-
tistical comparisons were performed with the Fisher exact
test or the 2 test for trend as appropriate. Association
between the LVEF and the index score was tested with the
Spearman rank correlation. A P value of .05 or less was
considered statistically significant for all tests.
RESULTS
Of the 96 patients, data were excluded on 19 who, after
initial evaluation, did not proceed to surgery for a variety
for reasons: five refused the operation, two had strokes, one
had a myocardial infarction and died during the assessment
period, one had a ruptured aneurysm and died the night
before the planned date of admission for elective repair, one
was found at operation to have a suprarenal aneurysm and
repair was not undertaken, one was denied elective repair in
view of advanced lung cancer, three were rejected because
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of poor general condition, and, finally, five were delayed or
canceled because they were considered high-risk, mainly,
on cardiac grounds. All five had an LVEF of less than 50%
and wall motion abnormalities, and three also had a left
ventricular (LV) aneurysm. Of these, one patient with a
LVEF of 10% and a huge LV aneurysm underwent coro-
nary catheterization that revealed inoperable coronary ar-
tery disease. The other two had LVEFs of 27% and 28%, LV
aneurysms, and small asymptomatic abdominal aortic an-
eurysms (AAAs). They were both considered as potential
candidates for one-stage or two-stage coronary artery by-
pass surgery, LV aneurysmectomy, and AAA repair, but the
overall operative risk was judged to be unacceptably high.
As a result, no further cardiac testing was planned and the
patients were treated expectantly with ultrasound scan sur-
veillance of AAA. The remaining two patients were consid-
ered high risk, on both clinical and radionuclide grounds,
and had their operations deferred to allow time for optimi-
zation of medical status and reassessment.
Seventy-seven patients underwent surgery and formed
the study population. This consisted of 59 men and 18
women, with an age range from 54 to 87 years and a mean
age (standard deviation [SD]) of 71.9 (7.1) years. There
were 66 patients with aneurysmal disease and 11 with
occlusive disease. The aneurysm size ranged between 4.0
cm and 10.0 cm, with a mean (SD) of 6.3 (1.1) cm. Patients
with occlusive disease had disabling claudication or rest
pain. The LVEF ranged from 25% to 88% (mean, 54%; SD,
12%). Forty-nine patients had LVEFs of more than 50%,
and 28 had LVEFs of 50% or less. Fifty patients had healthy
myocardial wall motion, and 27 showed wall abnormalities.
Twenty of these had both LVEFs of 50% or less and wall
abnormalities. The number of patients with each preoper-
ative risk factor is shown in Table I. More than half of our
patients had a previous history of ischemic heart disease. On
the basis of the index, 56 patients (73%) were at high risk
(two or more risk factors). No patient had five or all six risk
factors. Only 15 of the 77 patients were on -blocker
therapy before surgery. In the group of 19 patients who did
not undergo surgery, we had a higher proportion of pa-
tients at high risk (84% versus 73%), but this was not
statistically significant (3/19 versus 21/56; P  .385).
With the exception of three patients who refused to have
the operation and who had only one risk factor, the remain-
ing 16 patients were at high risk. In the surgical group,
there was one patient who underwent redo aortic surgery
and none who needed suprarenal cross-clamping. The me-
dian (interquartile range) cross-clamp time was 60 (20)
minutes, and the median (interquartile range) blood loss
was 900 (650) mL.
Fourteen patients (18%) had a total of 16 cardiac com-
plications develop. Ten patients had 11 major cardiac com-
plications (nine myocardial infarctions, one left ventricular
failure, and one unstable angina). Another four patients
had minor cardiac problems (three episodes of arrhythmias
and two episodes of angina). Eight patients died within 30
days, six from multiple organ failure, one from cardiac
causes, and one from hemorrhage. Table II shows the
likelihood of postoperative cardiac events in relation to the
number of preoperative risk factors. None of our patients
with one risk factor had cardiac problems after surgery,
although the event rate was 25% in those with two or more
risk factors. Therefore, the revised index proved to be a
satisfactory predictor of perioperative cardiac complications
(0/21 versus 14/56; P  .008). The preoperative use of
-blockers did not influence the rate of postoperative car-
diac events (3/14 versus 12/63; P  1.0). Neither the
cross-clamp time nor the intraoperative blood loss was
statistically different in those patients in whom cardiac
complications developed.
The LVEF alone was not a good predictor of cardiac
complications (8/28 versus 6/49; P  .1). Nevertheless,
the presence of wall abnormalities, either alone or com-
bined with an abnormal LVEF, were associated with a
higher incidence rate of cardiac complications (10/27 ver-
sus 4/50; P  .004; and 8/20 versus 6/57; P  .006
respectively).
Patients with higher index scores showed a tendency to
have lower LVEFs (Spearman rank correlation, r0.43;
P  .001; Fig). Furthermore, wall abnormalities, with or
without an abnormal LVEF, were more frequent in patients
with higher scores (ie, those with two or more risk factors;
24/27 versus 32/50; P .03; and 19/20 versus 37/57; P
 .009, respectively).
The sensitivity of the revised index in the prediction of
cardiac events was 100%, the specificity was 33%, the posi-
tive predictive value (PPV) was 25%, and the negative
predictive value (NPV) was 100%. In consideration of the
information provided with the MUGA scan, the sensitivity
of the LVEF in the identification of adverse cardiac periop-
erative outcomes was 57%, the specificity was 68%, the PPV
was 29%, and the NPV was 88%. The presence of wall
motion abnormalities had a sensitivity of 71%, a specificity
Table I. Revised Goldman Cardiac Risk Index and
number (%) of patients with each risk factor
Risk factors present No. of cases (n  77)
Ischemic heart disease 45 (58%)
Congestive heart failure 8 (10%)
Insulin-dependent diabetes 1 (1%)
Previous stroke or TIA 14 (18%)
Creatinine  2 mg/dL 5 (6%)
Table II. Cardiac morbidity in relation to the revised
Goldman Cardiac Risk Index
Risk factors present* Cardiac complications (%)
1 0/21 (0)
2 8/41 (20)
3 5/13 (38)
4 1/2 (50)
2 14/56 (25)
* No patient had 5 or 6 risk factors.
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of 73%, a PPV of 37%, and a NPV of 92%. Finally, the
combination of an abnormal ejection fraction with the
presence of wall motion abnormalities gave a sensitivity of
57%, a specificity of 81%, a PPV of 40%, and a NPV of 89%.
Patients judged with the index to be at high risk (two or
more risk factors) were further analyzed to find whether
there was any additional stratification to be gained with the
identification of those with abnormal MUGA scan results
(Table III). A combination of the LVEF and the index
could further stratify patients into a low-risk group (less
than two risk factors) with no complications, a medium-risk
group (two or more risk factors and healthy LVEF) with a
19% complication rate, and a high-risk group (two or more
risk factors and abnormal LVEF) with a 33% risk of cardiac
complications (P  .004, 2 test for trend). Similarly,
additional cardiac stratification could be obtained with the
combination of either the index with the wall abnormalities
alone or the index with both the wall abnormalities and
abnormal LVEF (0% versus 12% versus 42%; P  .0003;
and 0% versus 16% versus 42%; P  .0006, respectively, 2
test for trend; Table III).
DISCUSSION
The preoperative cardiac evaluation of patients who
undergo abdominal aortic surgery is often a challenging
task for surgical and anesthetic teams. The best means of
identifying patients who are at risk of perioperative cardiac
complications and who might benefit from further cardiac
testing, alternative management strategies, or preliminary
myocardial revascularization has yet to be defined. The
methods used for the cardiac risk assessment of such patients
include clinical evaluation, clinical scoring systems and
cardiac indices, exercise ECG or ambulatory ECG testing,
resting or stress echocardiography, myocardial perfusion
imaging, gated blood pool studies, and, even, coronary
angiography. In recent years, the availability of multiple tech-
nologies with which to evaluate risk, the diversity of practice
amongst different vascular units, and the confusion sur-
rounding the goals of perioperative assessment, prompted
the American College of Cardiology/American Heart As-
sociation to produce clinical practice guidelines so that
rational use of the previous investigations is achieved.7
Box and whisker plot of left ventricular ejection fraction and index. Those patients with higher index scores were more
likely to have lower ejection fractions.
Table III. Cardiac complications in relation to MUGA
scan findings and the revised Goldman Cardiac Risk
Index
MUGA scan findings All (%)
Number of risk factors
(%)
1 2
Ejection fraction
50% 6/49 (12) 0/17 (0) 6/32 (19)
50% 8/28 (29) 0/4 (0) 8/24 (33)
Wall abnormalities
Absent 4/50 (8) 0/18 (0) 4/32 (12)
Present 10/27 (37) 0/3 (0) 10/24 (42)
EF 50% and WA
No 6/57 (11) 0/20 (0) 6/37 (16)
Yes 8/20 (40) 0/1 (0) 8/19 (42)
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Nowadays, particular emphasis is given on clinical parame-
ters routinely available during the preoperative evaluation
and less so on specialized testing.16 This aims to identify
patients who may benefit from a specific cardiac treatment,
while avoiding unnecessary, costly and potentially hazard-
ous cardiac investigations.7
One of the main findings of this study was that the
revised Goldman Cardiac Risk Index proved to be an
effective means of stratifying cardiac risk before aortic sur-
gery. Although previous scoring systems and cardiac indices
have also been found to be useful in predicting cardiac
morbidity after abdominal aortic surgery,2,12,13 their pop-
ularity has been limited by their complexity. In its revised
form, the Cardiac Risk Index is attractive, quick, and sim-
ple, and can be readily incorporated into routine clinical
practice with minimum resource implications. In the sub-
group of patients who underwent abdominal aortic sur-
gery, Lee et al14 failed to show statistical relationship be-
tween the index score and cardiac complications. In
contrast, in this study, the index does seem to predict
satisfactorily the postoperative cardiac events. This is not
surprising because all five clinical factors of the six-variable
model (known ischemic heart disease, congestive heart
failure, insulin-dependent diabetes, cerebrovascular dis-
ease, and preexisting renal impairment) are recognized
predictors of perioperative morbidity and mortality after
infrarenal aortic surgery.17
In our series, routine estimation of the resting LVEF
was not an accurate predictor of cardiac complications.
Studies looking at whether a low LVEF is an independent
risk factor for cardiac events in the postoperative period
have produced conflicting results.7 Some studies report
that it is,18-25 and others report good results in patients
with poor ejection fractions (LVEF  35%).26,27 Of eight
studies that showed a positive relation between decreased
preoperative ejection fraction and postoperative mortality
or morbidity, five were prospective18-22 and one retrospec-
tive23 and, in two, the nature of the study was not clearly
stated.24,25 It has been suggested that, in the perioperative
phase, poor left ventricular function is mainly predictive of
congestive heart failure18 and, in critically ill patients,
death.7 It is also associated with significantly reduced over-
all long-term survival rate after successful surgery.27 How-
ever, resting LVEF was not found to be a consistent pre-
dictor of perioperative ischemic cardiac events.6,7 On the
other hand, our study showed the importance of myocar-
dial wall motion abnormalities in the prediction of postop-
erative cardiac complications. Patients with wall abnormal-
ities, both with or without an abnormal ejection fraction,
were more likely to have a postoperative cardiac problem.
This feature has seldom been addressed in previous reports,
and we were able to identify only one other similar study in
the literature.21 Despite this conflicting evidence about the
predictive value of the resting LVEF, MUGA scan remains
the second most popular preoperative cardiac assessment
tool amongst vascular surgeons and anesthetists in the
United Kingdom.4,5 Although the use rate varies consider-
ably, it is estimated that 13% to 19% of the vascular units in
the United Kingdom, and 39% of those to which the
investigation is available, use MUGA scan as the investiga-
tion of choice.5 In the United States, where a much greater
use of cardiologic investigation is taking place, preoperative
radioisotope LVEF is estimated in 33% of cases.3
This study showed that both the revised index and the
resting MUGA scan could identify patients at risk for
cardiac complications and that there was also a statistically
significant correlation between the index score and the
MUGA scan result. Furthermore, the index had a high
sensitivity (100%) and a low index score indicated a low risk
for cardiac complications (ie, good NPV). However, there
was a low specificity, and the prognostic implications of a
high index score were less well established (ie, poor PPV).
In contrast, despite its lower sensitivity and NPV, the
specificity of MUGA scanning, in this series, was superior to
that of the index. Because the revised index is at least as
good at predicting the cardiac morbidity as the presence of
wall abnormalities (with or without an abnormal LVEF),
one could argue that initial stratification, on the basis of
clinical criteria only, should be preferred to expensive non-
invasive radionuclide studies. However, the combination of
the index and the information provided with the MUGA
scan could further refine patient stratification. Focusing on
the group of patients who were considered with the index
to be at high risk, the combination of clinical and radionu-
clide data could identify medium-risk and high-risk groups
of patients for cardiac complications. On the other hand, in
the group of 21 patients judged with the index to be at
lower risk and in which we encountered no cardiac morbid-
ity at all, clearly, we cannot improve the apparent prediction
by subdividing them any further. Additional cardiac testing
is, therefore, unlikely to be helpful in this group of patients.
The introduction of the index in our clinical practice may
have both clinical and financial implications because this
would allow a reduction in unnecessary and expensive
noninvasive testing in patients stratified as being at low risk.
Had the index been applied in our patients, 21 (27%) of
them would not have needed a MUGA scan before surgery.
Many vascular surgeons already use clinical criteria to
stratify cardiac risk and reserve functional cardiac testing for
those with two or more risk factors. A typical example is the
use of Eagle criteria.28 We have shown previously that a
selective approach (ie, performing MUGA scanning only in
those patients with two or more risk factors) improves
cardiac risk stratification. Whether the results from this
study could be generalized to other functional cardiac tests,
such as the thallium or sestamibi myocardial perfusion
imaging and the dobutamine stress echocardiography, is
unclear. MUGA scan differs from myocardial perfusion
imaging studies or dobutamine echocardiography in that it
measures the LVEF and detects wall motion abnormalities
at rest. The latter studies are more invasive and use phar-
macologic stress to test for myocardial ischemia that is
manifested as reversible or fixed perfusion defects and wall
motion abnormalities. Many argue that stress tests are
superior because they may simulate, to a certain extent, the
stress exerted on the myocardium during cross-clamping
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and declamping of the aorta. However, there is still debate
on whether they can reliably predict adverse cardiac events
after abdominal aortic surgery. So far, no study has exam-
ined whether the combination of the revised index and
myocardial perfusion imaging or dobutamine echocardiog-
raphy can optimize cardiac risk stratification.
But what can be done for those patients deemed to be
at an increased cardiac risk? When faced with such a prob-
lem, vascular surgeons have the following options: cancel-
lation of the operation altogether in patients for whom the
cardiac risks are so high that they outweigh the potential
benefits of surgery; delay of surgery and ultrasonographic
surveillance of a smaller AAA until its size and the risk of
rupture has increased; altering perioperative management
(use of pulmonary artery flotation catheters, transfer to
high dependency unit the night before operation for fluid
loading and hemodynamic “tune up”); referral for coro-
nary angiography with a view to coronary revascularization;
delay of the upcoming operation to allow time for improve-
ment of cardiac status (ie prescribing a -blocker); or
finally, alternative surgery, such as endovascular AAA re-
pair. How to use the revised index for stratification, specif-
ically in aneurysm surgery, is another issue for debate.
Recent United Kingdom and United States small aneurysm
data would indicate that aneurysms with a diameter of less
than 5.5 cm do not gain mortality benefit. In the light of
these results, there may be a valid argument for a patient
with a high index score and a smaller AAA to be treated
conservatively. A patient with two or more Goldman risk
factors and a 5-cm AAA, for example, should be treated
with ultrasound scan surveillance and optimization of
medical/cardiac status, perhaps, with an addition of a
-blocker, until there is expansion to 5.5 cm. In fact, many
surgeons use 6 cm rather than 5.5 cm as a cut-off point at
which they recommend elective repair. When expansion has
been documented, a reevaluation of the risk-benefit ratio
should take place.
One should not forget that an aggressive approach to
cardiac assessment before aortic reconstruction is not with-
out hazards. Others have noted the negative impact of
cardiac workup.29 This can result in morbidity, delays, and
refusal to undergo vascular surgery. In this study, the
median time from cardiac workup to planned aortic surgery
was 7.6 weeks. Aneurysms rupture during the investigation
period, as seen in one of our patients. Cardiac stress testing
can be complicated with myocardial infarction or serious
arrhythmias, including ventricular fibrillation, and may
even precipitate rupture of a large AAA.30 Furthermore,
when considering preliminary myocardial revascularization
to enable the patient to “get through” the vascular surgery,
the additional mortality of the former should be taken into
account. Those at highest risk for noncardiac surgery are
also at high risk for coronary angioplasty or bypass surgery.
Therefore, it is likely that any decrease in risk produced with
coronary revascularization is offset by the additional risk
posed by the angiography and bypass surgery or angio-
plasty/stenting. Nowadays, according to American Col-
lege of Cardiology/American Heart Association guide-
lines, preliminary coronary revascularization should be
performed only if it is indicated in its own merit and is
appropriate for a small subset of patients at high risk.7
Because aneurysms are asymptomatic and the aim of elec-
tive aneurysmectomy is the prolongation of life, it may be
that patients would do better without us intervening on
either asymptomatic condition when discovered to have a
high cardiac risk.
Finally, two perioperative strategies, thought to be
particularly useful for patients at high risk, have emerged
recently: first, the perioperative use of -blockers, and,
second, the endovascular AAA stent-graft repair. The rou-
tine use of perioperative -blockade may represent the
single, simple, most efficient measure to improve outcome
in all patients who undergo major vascular surgery.31-33 In
addition, a recent study has shown -blockers to reduce
long-term cardiac death and myocardial infarction after
successful surgery.34 Endovascular stenting allows exclu-
sion of the aneurysm avoiding laparotomy or prolonged
aortic occlusion. This is thought to be especially useful for
patients considered to be high risk for elective open sur-
gery. However, conclusive evidence is lacking.35 In the
United Kingdom, this issue is currently being addressed by
a national multicenter randomized controlled trial: high-
risk patients are randomized either to endovascular repair
plus best medical treatment or to best medical treatment
alone. Until the results of this trial are known, endovascular
repair in patients at high risk should be considered cau-
tiously.
The 10% mortality rate in our study seems high for a
contemporary series of elective open aortic surgery. Liter-
ature review shows this to be around 5% but with a signif-
icant variation (0% to 12%).36 One potential reason for the
higher mortality rate in this series may be the fact that only
a small group of our patients were on -blockers before
surgery, although more than two thirds had history of
ischemic heart disease or congestive heart failure. It has
been shown that the presence of any of the preoperative
coronary artery disease, chronic heart failure, or previous
myocardial infarction indicates a 2.6 to 5.3 times greater
risk of mortality after elective repair.36 The fact that in this
study neither the cardiac event nor the mortality rate was
statistically different in the two groups (ie, -blockers ver-
sus no -blockers) is not reassuring because the -blocked
group was so small. Current recommendations are to treat
all patients who undergo major vascular surgery with
-blockers unless contraindicated.33,34
This study is the first to test the application of the
revised Goldman Cardiac Risk Index in an independent
series of patients who underwent abdominal aortic surgery.
The revised index proved to be an easy, useful, and cost-
effective means of evaluating cardiac risk before AAA repair
and could identify a low-risk group of patients in whom
additional cardiac testing is unlikely to be helpful. Routine
resting MUGA scan as a screening tool before abdominal
aortic surgery is not necessary. However, its selective use in
those patients deemed to be at high risk on clinical criteria
may further improve the cardiac risk stratification and the
JOURNAL OF VASCULAR SURGERY
May 2002948 Karkos et al
overall risk-versus-benefit assessment of candidates for aor-
tic surgery. This index is now routinely used by the authors,
and MUGA scan is only used on a selective basis in patients
at high risk.
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